You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE

Article metrics

Article menu
Immunology and inflammation
Original research
Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE

 

Online download statistics by month:

Online download statistics by month: February 2022 to August 2024

AbstractFullPdf
Feb 2022765764207
Mar 2022338341107
Apr 202218918772
May 202214214377
Jun 202210210256
Jul 202212312259
Aug 202213212958
Sep 202213213358
Oct 202215315252
Nov 2022989551
Dec 2022848221
Jan 20231019937
Feb 2023969844
Mar 2023938539
Apr 2023656364
May 202310210441
Jun 2023898930
Jul 202310810335
Aug 2023787929
Sep 2023706719
Oct 2023565320
Nov 2023878529
Dec 2023696924
Jan 2024484416
Feb 2024666426
Mar 2024909265
Apr 2024656428
May 2024918942
Jun 2024767232
Jul 2024857851
Aug 2024424017
Total383537871506